Moonset Health

Name: Moonset Health
Brand: Moonset Health

AI Native

AI scribing and beyond for hospice, home health, and post-acute senior care. Backed by Y Combinator

Est 2024|Raised $500K

LinkedIn 322|Website|FTEs 6|HQ Seattle, Washington, US

Published Jul 14, 2026

01Common complaints

- If the procurement team requires abundant independent third-party reviews on major review platforms prior to purchase: public coverage appears limited as of March 2026. - If a finalized SOC 2 Type II report is required at contract signing: vendor materials indicate SOC 2 controls are in an observation period; verify current status with the vendor. - If the organization requires a proven, deep integration with a specific hospice EHR (for example, single-click structured data writeback) and will not accept intermediary transfer methods. - If the organization needs a broad, multi-specialty ambient scribe across a health system; larger vendors may be better suited for enterprise-wide, multi-department deployments. - If transparent, self-serve pricing is required for small-team adoption; vendor materials indicate a sales-led pricing approach with annual terms.

Deal disqualifiers (poor fit)

Requirement for extensive third-party reviews prior to procurement.
Immediate requirement for a finalized SOC 2 Type II report (vendor indicates SOC 2 controls are in an observation period).
Environments requiring deep, native integration with a specific hospice EHR without intermediate copy/paste or import steps.

Limitations evident in vendor materials and gaps in public documentation

Pricing is not published publicly.
SOC 2 Type II control status appears to be in an observation period rather than a completed report as of the review date.
Public documentation of enterprise security features (SSO/SAML, SCIM, detailed audit logs) is limited.
Data residency and hosting region details are not clearly documented in public sources.

Roadmap items / regulatory context

Vendor FAQ references upcoming regulatory items and product improvements tied to regulation; buyers should request a documented roadmap and expected delivery timelines for features that address regulatory changes.

02Why they buy

Unique selling point elements supported by available evidence (vendor-reported)

Focus on hospice/post-acute documentation workflows rather than general-purpose scribing.
Compliance and eligibility-focused features (LCD/CMS completeness and audit-oriented checks) presented as core functionality.
Vendor-reported templates and topic libraries (vendor materials reference a library of topics and templates).

Areas where competitors may have advantages

Enterprise maturity, scale, and published third-party reviews.
Broader integration ecosystems and established partnerships for major EHRs.
Greater review transparency and longer track records in large deployments.

Why customers chose the vendor (inferred)

Based on vendor positioning, potential reasons for selection include: hospice and post-acute specialization compared with general-purpose scribes; compliance and LCD/CMS-oriented features; and workflows targeting IDG and hospice-specific note structures.

03Field reports

Review platform availability (Gartner/G2/TrustRadius/Capterra)

Searches did not surface a Moonset Health product listing or reviews on major review platforms such as Gartner Peer Insights, G2, TrustRadius, or Capterra as of the review date. Public third-party review coverage appears limited.

Vendor-published testimonials (context and caveats)

Vendor-published testimonials include statements attributed to nurses and other clinicians asserting reduced charting time, increased caseload capacity, and favorable comparisons to alternative dictation or voice-to-text approaches. These testimonials are curated by the vendor and do not include disclosed methodology, sample sizes, or objective measurements; they should therefore be treated as promotional claims unless verified through independent customer references or documented time studies.

Community / social proof (limited)

A comment on a hospice-staff subreddit referenced Moonset Health in the context of an agency considering AI-generated notes. This indicates some awareness or trial use within the hospice community but does not constitute structured, authoritative user feedback.

Common positive themes (as reported by vendor materials)

Reported benefits in vendor materials include reduced after-hours charting, increased note completeness and consistency, and improved clinician workload metrics. These items are vendor-reported and should be validated during due diligence.

Common criticisms / complaints (ecosystem-level concerns)

Independent, Moonset-specific negative reviews were not identified on major review platforms in the accessible search results. Broader concerns commonly cited about AI-assisted scribes (not specific to Moonset) include: - Generated notes typically act as draft documents and require clinician review. - Potential inaccuracies or missing clinical nuance in AI-generated text. - Privacy and BAA management concerns if used incorrectly. These ecosystem-level concerns should be investigated in vendor reference calls rather than assumed to apply to the vendor without product-specific evidence.

Why some customers might leave (hypotheses for validation)

Potential churn drivers to validate with references include: inconsistent note quality, friction transferring notes to the EHR, insufficient specialty-specific templates, pricing not justified by realized time savings, and procurement/security blockers.

Horizon Hospice case study (vendor-published)

Vendor-published case materials for Horizon Hospice claim significant per-nurse daily time savings and note that nurses added patients to their caseload. The materials also state rapid adoption and use of the product as a standard practice. Critical evaluation and methodology gaps: - The case study is authored by the vendor; measurement methodology, sample sizes, and instrumentation for time tracking are not disclosed. - It is unclear whether reported time savings are based on objective time-study data or self-reported estimates. - No counterfactual or comparison to alternative solutions is provided. Recommended questions for reference calls: - Request pre/post time-study details and measurement methodology. - Ask for note quality audit results and any compliance outcomes attributable to the product. - Request an estimate of the proportion of notes requiring major edits and which roles saw the largest benefits. - Clarify EHR transfer workflows and any pain points experienced during integration.

04Best fit

Company sizes

Based on the product’s positioning and sales-led approach, likely best fit candidates include mid-sized hospice and home health agencies (for example, mid-sized organizations) and multi-site providers with significant documentation workloads. Smaller agencies may be a fit if pricing and implementation overhead are appropriate. Large enterprise chains could be a fit but would require robust procurement artifacts and scalable admin/integration features.

Industries/verticals

Hospice providers
Home health agencies
Skilled nursing and other post-acute operators (vendor materials reference these settings)

Roles and personas

Economic buyer: VP Clinical Operations, COO, CIO/CTO (for integration and security), Compliance/QAPI leadership.
Primary users: Registered nurses, admissions nurses, case managers; potentially social workers, chaplains, and therapists if supported.

Pain points addressed

High after-hours documentation workload
Inconsistent notes and potential missed details
Audit and compliance risk (LCD/CMS completeness)
Clinician workload and turnover risk associated with documentation burden

Qualification criteria (good fit)

Agency has significant visit volume and documentation overhead.
Organization is willing to standardize note templates.
Organization has defined HIPAA/BAA requirements and governance in place.

05The pitch

What the product does (core value proposition)

Moonset Health provides a clinical documentation tool (an AI-assisted scribe) focused on hospice and post-acute care settings, notably hospice and home health. Clinicians record visits or interdisciplinary group (IDG) meetings on a mobile device; Moonset transcribes audio and drafts structured clinical notes with emphasis on regulatory and compliance completeness (for example, hospice LCD/CMS-oriented documentation). Vendor materials describe additional functionality beyond transcription, including automated QA checks of notes and identification of potential compliance gaps. The documented core workflow is: 1) record visit → 2) generate summary/note quickly → 3) clinician reviews/edits and transfers to EHR. Moonset is not positioned as an electronic health record (EHR) replacement. Notable vendor claims (require independent validation): - Vendor states notes can be generated in a matter of minutes. - Vendor states the product reduces clinician charting time and can produce material time savings. - Vendor describes compliance-focused features tuned to CMS/LCD requirements.

Target market and positioning

- Primary users: hospice and home health clinicians (vendor materials emphasize nurses but note support for broader care-team disciplines). - Buyers: hospice agencies and post-acute organizations (administration and operations leaders) seeking to reduce documentation burden, increase consistency, and limit compliance/audit risk. - Positioning: vertical clinical documentation tool oriented to hospice/post-acute workflows, differentiated from broad-market scribes through templates, workflows, and compliance-focused QA according to vendor materials.

Get a comprehensive analysis of Moonset Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →